Efficacy of Drug Treatment in Obsessive–Compulsive Disorder: a Meta-Analytic Review | The British Journal of Psychiatry | Cambridge Core (original) (raw)

References

American Psychiatric Association (1980) Diagnostic and Statistical Manual of Mental Disorders (3rd edn) . Washington, DC: APA.Google Scholar

American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders (3rd edn, revised) . Washington, DC: APA.Google Scholar

Amin, M. M., Ban, T. A., Pecknold, J. C., et al (1977) Clomipramine (Anafranil) and behaviour therapy in obsessive–compulsive and phobic disorders. Journal of Internal Medical Research, 5 (suppl. 5), 33–37.Google ScholarPubMed

Ananth, J., Pecknold, J. C., Van den Steen, N., et al (1981) Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis. Progess in Neuro-Psychopharmacology, 5, 257–262.CrossRefGoogle ScholarPubMed

Armitage, P. & Berry, G. (1987) Statistical Methods in Medical Research, 2nd edn. Oxford: Blackwell.Google Scholar

Balestrieri, M., Williams, P. & Wilkinson, G. (1988) Specialist mental health treatment in general practice: a meta-analysis. Psychological Medicine, 18, 711–717.Google Scholar

Begg, C. B. (1985) A measure to aid the interpretation of published clinical trials. Statistics in Medicine, 4, 1–9.CrossRefGoogle ScholarPubMed

Brand, R. & Kragt, H. (1992) Importance of trends in the interpretation of an overall odds ratio in the meta-analysis of clinical trials. Statistics in Medicine, 11, 2077–2082.Google Scholar

Cassano, G. B., Castrogiovanni, P., Mauri, M., et al (1981) A multicenter controlled trial in phobic-obsessive psychoneurosis. The effect of clomipramine and of its combinations with haloperidol and diazepam. Progress in Neuro-Psychopharmacology, 5, 129–138.Google Scholar

Chalmers, T. C., Levin, H., Sacks, H. S., et al (1987) Meta-analysis of clinical trials as a scientific discipline. I: control of bias and comparison with large cooperative trials. Statistics in Medicine, 6, 315–325.CrossRefGoogle Scholar

Chouinard, G. (1992) Sertraline in the treatment of obsessive-compulsive disorder: two double-blind, placebo-controlled studies. International Clinical Psychopharmacology, 7 (suppl. 2), 37–41.CrossRefGoogle ScholarPubMed

Chouinard, G., Goodman, W., Greist, J., et al (1990) Results of a double-blind placebo controlled trial of a new serotonin reuptake inhibitor, sertraline, in the treatment of obsessive–compulsive disorder. Psychopharmacology Bulletin, 26, 279–284.Google ScholarPubMed

Christensen, H., Hadzi-Pavlovic, D., Andrews, G., et al (1987) Behavior therapy and tricyclic medication in the treatment of obsessive–compulsive disorder: a quantitative review. Journal of Consulting and Clinical Psychology, 55, 701–711.CrossRefGoogle ScholarPubMed

Clomipramine Collaborative Study Group (1991) Clomipramine in the treatment of patients with obsessive–compulsive disorder. Archives of General Psychiatry, 48, 730–738.Google Scholar

Collins, R., Gray, R., Godwin, J., et al (1987) Avoidance of large biases in the assessment of moderate treatment effects: the need for systematic overviews. Statistics in Medicine, 6, 245–250.CrossRefGoogle ScholarPubMed

Cottreaux, J., Mollard, E., Bouvard, M., et al (1990) A controlled study of fluvoxamine and exposure in obsessive–compulsive disorder. International Clinical Psychopharmacology, 5, 17–30.CrossRefGoogle Scholar

Cottreaux, J., Mollard, E., Bouvard, M., et al (1993) Exposure therapy, fluvoxamine, or combination treatment in obsessive–compulsive disorder: one-year follow up. Psychiatry Research, 49, 63–75.CrossRefGoogle Scholar

Demets, D. L. (1987) Methods for combining randomized clinical trials: strengths and limitations. Statistics in Medicine, 6, 341–348.CrossRefGoogle ScholarPubMed

DenBoer, J. A., Westenberg, H. G. M., Kamerbeek, W. D. J., et al (1987) Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine. International Clinical Psychopharmacology, 2, 21–32.CrossRefGoogle Scholar

De Veaugh-Geiss, J., Landau, P. & Katz, R. (1989) Preliminary results from a multicenter trial of clomipramine in obsessive–compulsive disorder. Psychopharmacology Bulletin, 25, 36–40.Google Scholar

De Veaugh-Geiss, J., Moroz, G., Biederman, J., et al (1992) Clomipramine hydrochloride in childhood and adolescent obsessive–compulsive disorder – a multicenter trial. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 45–49.CrossRefGoogle ScholarPubMed

Dickersin, K., Hewitt, P., Mutch, L., et al (1985) Perusing the literature: comparison of Medline searching with a perinatal trials database. Controlled Clinical Trials, 6, 306–317.CrossRefGoogle ScholarPubMed

Easterbrook, P. J. (1992) Directory of registries of clinical trials. Statistics in Medicine, 11, 345–423.Google Scholar

Eccleston, D. (ed.) (1993) The economic evaluation of antidepressant drug therapy. British Journal of Psychiatry, 163 (suppl. 20), 5–6.CrossRefGoogle Scholar

Fiske, D. W. (1983) The meta-analytic revolution in outcome research. Journal of Consulting and Clinical Psychology, 51, 65–70.CrossRefGoogle ScholarPubMed

Flament, M. F., Rapoport, J. L., Berg, C. J., et al (1985) Clomipramine treatment of childhood obsessive–compulsive disorder. A double-blind controlled study. Archives of General Psychiatry, 42, 977–983.CrossRefGoogle ScholarPubMed

Foa, E. B. & Emmelkamp, P. M. G. (1983) Failures in Behavior Therapy. New York: John Wiley.Google Scholar

Foa, E. B., Steketee, G., Kozak, M. J., et al (1987) Imipramine and placebo in the treatment of obsessive–compulsives: their effect on depression and on obsessional symptoms. Psychopharmacology Bulletin, 23, 8–11.Google ScholarPubMed

Freeman, C. P. L., Trimble, M. R., Deakin, J. F. W., et al Fluvoxamine or clomipramine in the treatment of obsessive–compulsive disorder? A multicenter, randomized, double-blind, parallel group comparison. Journal of Clinical Psychiatry. Google Scholar

Goodman, W. K., Price, L. H., Rasmussen, S. A., et al (1989a) Efficacy of fluvoxamine in obsessive–compulsive disorder. A double-blind comparison with placebo. Archives of General Psychiatry, 46, 36–44.Google Scholar

Goodman, W. K., Price, L. H., Rasmussen, S. A., et al (1989b) The Yale-Brown Obsessive Compulsive Scale, I: development, use, and reliability. Archives of General Psychiatry, 46, 1006–1011.CrossRefGoogle ScholarPubMed

Goodman, W. K., Price, L. H., Rasmussen, S. A., et al (1989c) The Yale-Brown Obsessive Compulsive Scale, II: validity. Archives of General Psychiatry, 46, 1012–1016.CrossRefGoogle ScholarPubMed

Goodman, W. K., Price, L. H., Delgado, P. L., et al (1990) Specificity of serotonin reuptake inhibitors in the treatment of obsessive–compulsive disorder. Comparison of fluvoxamine and desipramine. Archives of General Psychiatry, 47, 577–585.CrossRefGoogle ScholarPubMed

Goodman, W. K., McDougle, C. J. & Price, L. H. (1992) Pharmacotherapy of obsessive–compulsive disorder. Journal of Clinical Psychiatry, 53 (suppl. 4), 29–37.Google ScholarPubMed

Goodman, W. K., McDougle, C. J., Barr, L. C., et al (1993) Biological approaches to treatment-resistant obsessive–compulsive disorder. Journal of Clinical Psychiatry, 54 (suppl. 6), 16–26.Google Scholar

Greist, J. H., Jefferson, J. W., Rosenfeld, R., et al (1990) Clomipramine and obsessive–compulsive disorder: a placebo-controlled double-blind study of 32 patients. Journal of Clinical Psychiatry, 51, 292–297.Google Scholar

Greist, J. H., Chouinard, G., DuBoff, E., et al Double-blind parallel comparison of three fixed doses of sertraline and placebo in out-patients with obsessive–compulsive disorder. Archives of General Psychiatry. Google Scholar

Guscott, R. & Taylor, L. (1994) Lithium prophylaxis in recurrent affective illness. Efficacy, effectiveness and efficiency. British Journal of Psychiatry, 164, 741–746.Google Scholar

Hamilton, M. (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56–62.Google Scholar

Hedges, L. V. (1981) Distribution theory for Glass's estimator of effect size and related estimators. Journal of Educational Statistics, 6, 107–128.CrossRefGoogle Scholar

Hewlett, W. A., Vinogradov, S. & Agras, W. S. (1992) Clomipramine, clonazepam, and clonidine treatment of obsessive–compulsive disorder. Journal of Clinical Psychopharmacology, 12, 420–430.Google Scholar

Hoehn-Saric, R., McLeod, D. R., Zimmerli, W. D., et al (1993) Symptoms and physiologic manifestations in obsessive–compulsive patients before and after treatment with clomipramine. Journal of Clinical Psychiatry, 54, 272–276.Google Scholar

Insel, T. R., Murphy, D. L., Cohen, R. M., et al (1983) Obsessive–compulsive disorder. A double-blind trial of clomipramine and clorgyline. Archives of General Psychiatry, 40, 605–612.Google Scholar

Insel, T. R., Mueller, E. A., Alterman, I., et al (1985) Obsessive–compulsive disorder and serotonin: is there a connection? Biological Psychiatry, 20, 1174–1188.CrossRefGoogle ScholarPubMed

Jaskari, M. O. (1980) Observations on mianserin in the treatment of obsessive neuroses. Current Medical Research and Opinion, 6, 128–131.CrossRefGoogle Scholar

Jenike, M. A., Baer, L., Summergrad, P., et al (1989) Obsessive–compulsive disorder: a double-blind, placebo–controlled trial of clomipramine in 27 patients. American Journal of Psychiatry, 146, 1328–1330.Google Scholar

Jenike, M. A., Hyman, S., Baer, L., et al (1990a) A controlled trial of fluvoxamine in obsessive–compulsive disorder: implications for a serotonergic theory. American Journal of Psychiatry, 147, 1209–1215.Google ScholarPubMed

Jenike, M. A., Baer, L., Summergrad, P., et al (1990b) Sertraline in obsessive–compulsive disorder: a double-blind comparison with placebo. American Journal of Psychiatry, 147, 923–928.Google Scholar

Jenike, M. A., Baer, L., Summergrad, P. & Greist, J. H. (1990c) Clomipramine versus fluoxetine in obsessive–compulsive disorder: a retrospective comparison of side-effects and efficacy. Journal of Clinical Psychopharmacology, 10, 122–124.CrossRefGoogle ScholarPubMed

Jermain, D. M. & Crismon, M. L. (1990) Pharmacotherapy of obsessive–compulsive disorder. Pharmacotherapy, 10, 175–198.Google Scholar

Kahn, R. S., Westenberg, H. G. M., Verhoeven, W. M. A., et al (1987) Effect of a serotonin precursor and uptake inhibitor in anxiety disorders; a double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo. International Clinical Psychopharmacology, 2, 33–45.Google Scholar

Karabanow, O. (1977) Double-blind controlled study in phobias and obsessions. Journal of Internal Medical Research, 5 (suppl. 5), 42–48.Google ScholarPubMed

Leonard, H., Swedo, S., Rapoport, J. L., et al (1988) Treatment of childhood obsessive compulsive disorder with clomipramine and desmethylimipramine: a double-blind crossover comparison. Psychopharmacology Bulletin, 24, 93–95.Google Scholar

Leonard, H., Swedo, S., Rapoport, J. L., et al (1989) Treatment of obsessive–compulsive disorder with clomipramine and desipramine in children and adolescents. Archives of General Psychiatry, 46, 1088–1092.CrossRefGoogle ScholarPubMed

Leonard, H., Swedo, S., Lenane, M. C., et al (1993) A 2 to 7-year follow-up study of 54 obsessive–compulsive children and adolescents. Archives of General Psychiatry, 50, 429–439.CrossRefGoogle ScholarPubMed

Mallya, G. K., White, K., Waternaux, C., et al (1992) Short- and long-term treatment of obsessive–compulsive disorder with fluvoxamine. Annals of Clinical Psychiatry, 4, 77–80.CrossRefGoogle Scholar

Mantel, N. & Haenszel, W. (1959) Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute, 22, 719–748.Google Scholar

March, J. S., Gutzman, L. D., Jefferson, J. W., et al (1989) Serotonin and treatment in obsessive–compulsive disorder. Psychiatric Developments, 1, 1–18.Google Scholar

Marks, I. (1982) Are there anticompulsive or antiphobic drugs? Review of the evidence. Psychopharmacology Bulletin, 18, 78–84.Google Scholar

Marks, I. (1987) Fears, Phobias, and Rituals. New York: Oxford University Press.Google Scholar

Marks, I., Stern, R. S., Mawson, D., et al (1980) Clomipramine and exposure for obsessive–compulsive rituals: I. British Journal of Psychiatry, 136, 1–25.Google Scholar

Marks, I., Lelliott, P., Basoglu, M., et al (1988) Clomipramine, self-exposure and therapist-aided exposure for obsessive–compulsive rituals. British Journal of Psychiatry, 152, 522–534.Google Scholar

Mavissakalian, M. & Michelson, L. (1983) Tricyclic antidepressants in obsessive–compulsive disorder. Antiobsessional or antidepressant agents? Journal of Nervous and Mental Disease, 171, 301–306.CrossRefGoogle ScholarPubMed

Mavissakalian, M., Turner, S. M., Michelson, L., et al (1985) Tricyclic antidepressants in obsessive–compulsive disorder: anti-obsessional or antidepressant agents? II. American Journal of Psychiatry, 142, 572–576.Google Scholar

Mavissakalian, M., Jones, B., Olson, S., et al (1990) Clomipramine in obsessive–compulsive disorder: clinical response and plasma levels. Journal of Clinical Psychopharmacology, 10, 261–268.Google Scholar

Mawson, D., Marks, I. M. & Ramm, L. (1982) Clomipramine and exposure for chronic obsessive–compulsive rituals: III. Two year follow-up and further findings. British Journal of Psychiatry, 140, 11–18.CrossRefGoogle ScholarPubMed

Montgomery, S. A. (1980) Clomipramine in obsessional neurosis: a placebo-controlled trial. Pharmaceutical Medicine, 1, 189–192.Google Scholar

Montgomery, S. A., McIntyre, A., Osthereider, M., et al (1993) A double-blind placebo-controlled study of fluoxetine in patients with DSM–III–R obsessive–compulsive disorder. European Neuropsychopharmacology, 3, 143–152.Google Scholar

Murphy, D. L., Pickar, D. & Alterman, I. S. (1982) Methods for the quantitative assessment of depressive and manic behavior. In The Behavior of Psychiatric Patients (eds E. L. Burdock, A. Sudilovsky & S. Gershon), pp. 355–392. New York: Marcel Dekker.Google Scholar

Murphy, D. L., Pato, M. T. & Pigott, T. A. (1990) Obsessive–compulsive disorder: treatment with serotonin-selective uptake inhibitors, azapirones, and other agents. Journal of Clinical Psychopharmacology, 10, 91S–100S.Google Scholar

Pato, M. T., Pigott, T. A., Hill, J. L., et al (1991) Controlled comparison of buspirone and clomipramine in obsessive–compulsive disorder. American Journal of Psychiatry, 148, 127–129.Google Scholar

Perse, T. (1988) Obsessive–compulsive disorder: a treatment review. Journal of Clinical Psychiatry, 49, 48–55.Google Scholar

Perse, T., Greist, J. H., Jefferson, J. W., et al (1987) Fluvoxamine treatment of obsessive–compulsive disorder. American Journal of Psychiatry, 144, 1543–1548.Google Scholar

Pigott, T. A., Pato, M. T., Bernstein, S. E., et al (1990) Controlled comparison of clomipramine and fluoxetine in the treatment of obsessive–compulsive disorder. Archives of General Psychiatry, 47, 926–932.Google Scholar

Pigott, T. A., L'Heureux, F., Rubenstein, C. S., et al (1992) A double-blind, placebo controlled study of trazodone in patients with obsessive–compulsive disorder. Journal of Clinical Psychopharmacology, 12, 156–162.Google Scholar

Prasad, A. (1984) A double blind study of imipramine versus zimelidine in treatment of obsessive compulsive neurosis. Pharmacopsychiatry, 17, 61–62.Google Scholar

Prioleau, L., Murdock, M. & Brody, N. (1983) An analysis of psychotherapy versus placebo studies. Behavioral and Brain Sciences, 6, 275–310.Google Scholar

Rapoport, J. (1989) The Boy Who Couldn't Stop Washing. New York: EP Dutton.Google Scholar

Rapoport, J., Elkins, R. & Mikkelsen, E. (1980) A clinical controlled trial of chlorimipramine in adolescents with obsessive–compulsive disorder. Psychopharmacology Bulletin, 16, 61–63.Google Scholar

Rasmussen, S. A. & Eisen, J. L. (1992) The epidemiology and differential diagnosis of obsessive–compulsive disorder. Journal of Clinical Psychiatry, 53 (suppl. 4), 4–10.Google Scholar

Rasmussen, S. A. & Eisen, J. L. & Pato, M. T. (1993) Current issues in the pharmacologic management of obsessive–compulsive disorder. Journal of Clinical Psychiatry, 54 (suppl. 6), 4–9.Google Scholar

Rasmussen, S. A., Goodman, W. K., Greist, J. H., et al Fluvoxamine in the treatment of obsessive–compulsive disorder: a multicenter double-blind placebo-controlled study in outpatients. American Journal of Psychiatry. Google Scholar

Regier, D. A., Farmer, M. E., Rae, D. S., et al (1993) One-month prevalence of mental disorders in the United States and sociodemographic characteristics: the Epidemiologic Catchment Area study. Acta Psychiatrica Scandinavica, 8, 35–47.Google Scholar

Ricciardi, J. M. (1993) Frequency of diagnosis of obsessive–compulsive disorder (letter). American Journal of Psychiatry, 4, 682.Google Scholar

Robins, L. N., Helzer, J. E., Weissman, M. M., et al (1984) Lifetime prevalence of specific psychiatric disorders in three sites. Archives of General Psychiatry, 41, 949–958.Google Scholar

Robins, L. N. & Regier, D. A. (ed.) (1991) Psychiatric Disorders in America. The Epidemiologic Catchment Area Study, pp. 360–363. New York: The Free Press.Google Scholar

Rosenthal, R. (1979) The ‘file drawer problem’ and tolerance for null results. Psychological Bulletin, 86, 638–641.CrossRefGoogle Scholar

Rosenthal, R. (1984) Meta-analytic Procedures for Social Research. Beverly Hills: Sage.Google Scholar

Rosenthal, R. & Rubin, D. B. (1982) Comparing effect sizes of independent studies. Psychological Bulletin, 92, 500–504.CrossRefGoogle Scholar

Saiz Ruiz, J., Lopez-Ibor, J. J. Jr., Cottreaux, J., et al (1992) Double-blind comparison of fluoxetine and clomipramine in obsessive–compulsive disorder. European Neuropsychopharmacology, 2, 204–205.CrossRefGoogle Scholar

Simes, R. J. (1987) Confronting publication bias: a cohort design for meta-analysis. Statistics in Medicine, 6, 11–29.Google Scholar

Smeraldi, E., Erzegovesi, S., Bianchi, I., et al (1992) Fluvoxamine v. clomipramine treatment in obsessive–compulsive disorder: a preliminary study. New Trends in Experimental and Clinical Psychiatry, 8, 63–65.Google Scholar

Smith, M. L. & Glass, G. V. (1977) Meta-analysis of psychotherapy outcome studies. American Psychologist, 32, 752–760.Google Scholar

Smith, M. L. & Glass, G. V. & Miller, T. I. (1980) The Benefits of Psychotherapy. Baltimore: Johns Hopkins University Press.Google Scholar

Song, F., Freemantle, N., Sheldon, T. A., et al (1993) Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. British Medical Journal, 306, 683–687.Google Scholar

Spitzer, R. L., Endicott, J. & Robins, E. (1978) Research Diagnostic Criteria (RDC) for a Selected Group of Functional Disorders (3rd edn). New York: New York State Psychiatric Insitute.Google Scholar

Strube, M. J. & Hartmann, D. P. (1983) Meta-analysis: Techniques, applications, and functions. Journal of Consulting and Clinical Psychology, 51, 14–27.Google Scholar

Thoren, P., Asberg, M., Cronholm, B., et al (1980) Clomipramine treatment of obsessive–compulsive disorder. I. A controlled clinical trial. Archives of General Psychiatry, 37, 1281–1285.Google Scholar

Tollefson, G. D., Rampey, A. H. & Genduso, L. A. (1993) A fixed-dose placebo-controlled trial of fluoxetine in obsessive–compulsive disorder. Proceedings of the 33rd NIMH New Clinical Drug Evaluation Unit Program (NCDEU). .Google Scholar

Vallejo, J., Olivares, J., Marcos, T., et al (1992) Clomipramine versus phenelzine in obsessive–compulsive disorder. A controlled clinical trial. British Journal of Psychiatry, 161, 665–670.Google Scholar

Volavka, J., Neziroglu, F. & Yaryura-Tobias, J. A. (1985) Clomipramine and imipramine in obsessive–compulsive disorder. Psychiatry Research, 14, 85–93.CrossRefGoogle ScholarPubMed

Wheadon, D. E., Bushnell, W. D. & Steiner, M. (1993) A fixed dose comparison of 20, 40, or 60 mg paroxetine to placebo in the treatment of obsessive–compulsive disorder. Poster presented at the American College of Neuropharmacology Meeting, Puerto Rico, December 1993.Google Scholar

Wilkinson, G., Balestrieri, M., Ruggeri, M., et al (1991) Meta-analysis of double-blind placebo-controlled trials of antidepressants and benzodiazepines for patients with panic disorders. Psychological Medicine, 21, 991–998.Google Scholar

Wood, A., Tollefson, G. D. & Birkett, M. (1993) Pharmacotherapy of obsessive–compulsive disorder – experience with fluoxetine. International Clinical Psychopharmacology, 8, 301–306.Google Scholar

Yaryura-Tobias, J. A., Neziroglu, F. & Bergman, L. (1976) Chlorimipramine, for obsessive–compulsive neurosis: an organic approach. Current Therapeutic Research, 20, 541–548.Google Scholar

Yusuf, S. (1987) Obtaining medically meaningful answers from an overview of randomized clinical trials. Statistics in Medicine, 6, 281–286.Google Scholar

Zohar, J. & Insel, T. R. (1987) Obsessive–compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology. Biological Psychiatry, 22, 667–687.Google Scholar